Due to the current application of AnxA5 as tumor imaging tools in clinical studies61, such approaches have high clinical feasibility and translational potential and may lead to the development of novel and readily adaptable immunotherapeutic for the treatment of cancer. The gene discussed is ANXA5; the disease is neoplasm.